QUCY Quantum Cyber N.V.

BEARISH Impact: 7/10 S-3
Horizon weeks Filed Jun 4, 2026 Processed 1d 5h ago SEC 0001213900-26-064908
Shelf registration — potential dilution
Latest settled — T+1d
QUCY ▼ -5.58% at T+1d
SHORT call ✓ call won +5.58% · α vs SPY +3.01% · entry $2.33 → $2.20
Next anchor: T+5d in 6d
Currently $2.20 · +5.58% from $2.33 entry (call sign-flipped)
Entry anchored
Jun 4, 11:32 AM ET
via Databento tick
T+1d
-5.58%
call +5.58% · α +3.01%
$2.20
settled 9h ago
T+5d
call — · α —
in 6d
T+20d
call — · α —
in 28d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Quantum Cyber N.V. filed a universal shelf registration statement on Form S-3 to register up to $250,000,000 in securities (ordinary shares, preferred shares, warrants, subscription rights, and/or units) for future sale. The company has no revenue, an accumulated deficit of ~$110M, and a going-concern qualification in its most recent 10-Q, making this a desperation capital raise to fund a pivot from cancer diagnostics to AI/quantum drone technology.

Key Financial Metrics

Offering Size
$250.0M

Actionable Insight

Expect significant dilution over the coming months as the company taps this shelf to fund operations and its pivot to drone technology. The going-concern warning and zero-revenue profile make any equity issuance highly dilutive. Monitor for prospectus supplements that will reveal actual offering size, pricing, and structure — likely an ATM or registered direct offering at a discount to market.

Key Facts

  • Shelf registration of up to $250,000,000 — ~4.5x current market cap of $56M
  • Zero revenue in Q1 2026; net loss of $5.1M; accumulated deficit of ~$110.0M
  • Going-concern qualification in the March 31, 2026 10-Q
  • Cash balance of $4.45M at quarter-end; operating cash burn of ~$2.7M in Q1 2026
  • Company pivoted from cancer diagnostics (Mainz Biomed) to AI/quantum drone technology in April 2026
  • Stock closed at $2.45 on June 2, 2026, down from $3.56 on May 21, 2026 (public float calculation date)

Financial Impact

Up to $250M in potential dilution — over 4x the current $56M market cap. The company has no revenue and is burning ~$2.7M/quarter in operating cash.

dilutionmarket_capcash_runway

Risk Factors

  • Massive dilution: $250M shelf is ~4.5x current market cap
  • Going-concern risk: company has no revenue, negative equity working capital, and substantial doubt about ability to continue
  • Business model pivot risk: transition from cancer diagnostics to AI/quantum drones is unproven with no revenue or contracts
  • Nasdaq listing risk: continued low share price could trigger minimum bid price compliance issues

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001213900-26-064908
Document: ea029338801ex5-1.htm0001213900-26-064908
Document: ea029338801ex-fee.htm0001213900-26-064908
Document: ea029338801ex5-2.htm0001213900-26-064908
Document: ea029338801ex23-1.htm0001213900-26-064908
Document: 0001213900-26-064908-index-headers.html0001213900-26-064908
Document: 0001213900-26-064908-index.html0001213900-26-064908
Document: 0001213900-26-064908.txt0001213900-26-064908
19 reports for QUCY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for QUCY — sortable, filterable
Type Now
Jun 5, 2026
today
8-K
NEUTRAL ★ 3/10
$2.14 awaiting T+1awaiting T+1$2.20 (+2.80%)
Jun 4, 2026
1d ago
S-3
BEARISH ★ 7/10
$2.33 $2.20▲ +5.58%▲ +3.01%$2.20 (+5.58%)
Jun 3, 2026
2d ago
8-K
MIXED ★ 5/10
$2.46 $2.33▼ −5.28%▼ −5.68%$2.20 (−10.57%)
Jun 3, 2026
2d ago
Press Release
NEUTRAL ★ 3/10
$2.46 $2.33▼ −5.28%▼ −5.68%$2.20 (−10.57%)
Jun 2, 2026
3d ago
Press Release
NEUTRAL ★ 4/10
$2.45 $2.46▲ +0.41%▲ +1.10%$2.20 (−10.20%)
May 27, 2026
9d ago
Press Release
NEUTRAL ★ 4/10
$2.93 $2.98▲ +1.71%▲ +1.15%$2.20 (−24.91%)
May 26, 2026
10d ago
Press Release
BULLISH ★ 7/10
$3.47 $2.93▼ −15.56%▼ −15.58%$2.20 (−36.60%)
May 22, 2026
14d ago
144
NEUTRAL ★ 3/10
$3.33 $3.47▲ +4.20%▲ +3.62%$2.20 (−33.93%)
May 20, 2026
16d ago
Press Release
NEUTRAL ★ 4/10
$3.29 $3.56▲ +8.21%▲ +8.01%$2.20 (−33.13%)
May 18, 2026
18d ago
144
BEARISH ★ 5/10
$2.52 $3.29▼ −30.56%▼ −29.52%$2.20 (+12.70%)
Showing 10 of 19

US Market Status

Market Closed — Opens Mon (64h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access